POST SUMMARY: Having a patient insights person is not enough today, you need to execute on the insights, but expect bumps in the road along the way. Continue reading »
POST SUMMARY: To develop a great mobile health app think value to the patient not marketing. Continue reading »
POST SUMMARY: Researchers find that nearly 70 percent of Americans are on at least one prescription drug, and more than half receive at least two prescriptions, but why medications are prescribed should not be determined by pharma pressure on medical/scientific guidelines. Continue reading »
POST SUMMARY: Sooner or later biopharma marketers are going to have to engage health seekers to provide value beyond posted static information. It’s not going to easy and there are sure to be some bumps along the way, but it’s the only way for DTC marketing to stay relevant. Continue reading »
POST SUMMARY: While few would dispute that the pace of innovation has picked up, the outlook varies from one company to another — and many appear to be relying more on mergers and acquisitions than homegrown R&D to deliver new products. A record $250bn worth of deals was struck in 2014, and bankers and executives predict more this year as companies tap plentiful cash and cheap credit. But, eventually there won’t be as many companies to purchase and once again the focus is going to turn on marketing to meet sales goals. Continue reading »
POST SUMMARY: I spent a lot of time this year leading qualitative research along with analyzing quantitative research. I keep all the research report findings in a binder and while it’s true that a lot of the insights can’t be applied across all health conditions there are some common needs/wants. Here are some of the most common..
Continue reading »
If pharma companies do not join the digital dialogue and influence the conversation, they will lose an opportunity to shape it, and they may be put on the defensive trying to refute the statements made by those that do take part. Continue reading »
Pfizer is adding humor to the battle over the post-menopause prescription market. Launched last week the “Let’s talk about change” campaign is a departure from the company’s recent “Tune into Menopause” campaign that featured Kim Cattrall. As someone who has sat in a LOT of research with women this YouTube video really misses the mark. Continue reading »
POST SUMMARY: It’s hard to have a meeting to discuss new DTC marketing initiatives without the dreaded ROI discussion. I understand that the current business environment in biopharma is about creating customers, but the problem is that consumers today don’t want to be sold. If you really want to closer to your customers, find ways to help them make better healthcare decisions and get good credible health information. Continue reading »
POST SUMMARY: Drugmakers and Internet companies are quietly joining forces to link U.S. pharmacy records with online accounts to target ads to people based on their health conditions and the prescription drugs they buy but what do patients have to say? Continue reading »
POST SUMMARY: While most pharma companies are staying at arm’s length from social media there are a lot of insights into how patients, and caregivers, are thinking about their health problems and treatments.
Continue reading »